Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578

Humanized mice in translational biomedical research

Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature reviews. Immunology · doi:10.1038/nri2017 · Cited by 1,393

Humanized mice in translational biomedical research

Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036

Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts

Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016) · Nature · doi:10.1038/nature19815 · Cited by 840

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

Melkus, M. W., Estes, J. D., Padgett‐Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T., & Garcia, J. V. (2006) · Nature Medicine · doi:10.1038/nm1431 · Cited by 653

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639

Fetomaternal immune cross-talk and its consequences for maternal and offspring's health

Arck, P., & Hecher, K. (2013) · Nature Medicine · doi:10.1038/nm.3160 · Cited by 609

AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3

Wunderlich, M., Chou, F.-S., Link, K. A., Mizukawa, B., Perry, R. L., Carroll, M., & Mulloy, J. C. (2010) · Leukemia · doi:10.1038/leu.2010.158 · Cited by 415

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes

Chang, C., Fontes, J., Peterlin, M., & Flavell, R. (1994) · Journal of Experimental Medicine · doi:10.1084/jem.180.4.1367 · Cited by 352

Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients With Acute Myocardial Infarction Based on Individual Patient Data

Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bartunek, J., Marbán, E., Aßmus, B., Henry, T. D., Traverse, J. H., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304346 · Cited by 313

The therapeutic potential of natural killer (NK) cells to combat aging and age-related diseases

Bari, R., Kang, L., Gosiewska, A., & HARIRI, R. J. (2026) · Discover Immunity. · doi:10.1007/s44368-026-00021-2 · Cited by 1

Innovative regenerative genetic and nano therapies for diabetes and metabolic disease

Spanorriga, M., Fragoulis, C., Bega, I., Mavromoustakou, K., Gatsouniotis, I., Lontou, S.-P., Dimitriadis, K., Aznaouridis, K., Ktenopoulos, N., Thanopoulou, A., et al. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101461 · Cited by 1

From edits to Circuits: Nucleic acid therapeutics for Correcting human disease

Guinn, M. T., Sinenko, I., Ghanta, R. K., & Omid Veiseh, A. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103351 · Cited by 1

Stem cell–based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection

Li, Z., Kang, Y., & Niu, Y. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70211 · Cited by 1

Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy

You, Z., Lin, Z., Zhang, Y., Xu, L., & Zhang, W. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105414 · Cited by 2

A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study

Jin, S., Liao, Z., Yan, S., Yan, L., Yao, W., Shang, J., Tang, F., 朱子玲, Wu, D., Rajakumaraswamy, N., et al. (2026) · Blood · doi:10.1182/blood.2025032112 · Cited by 1

Induced Pluripotent Stem Cells in Corneal Regeneration: Biological Progress, Translational Barriers and Clinical Outlook

Al-amarat, T. S., & Mehta, J. S. (2026) · Biomedicines · doi:10.3390/biomedicines14061323 · Cited by 1

Biomaterials for clinical therapy utilizing cells differentiated from human pluripotent stem cells

Higuchi, A., Wang, T., Kang, X., Tian, Z., Sung, T., & Umezawa, A. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100860 · Cited by 1

Parkinson's Disease Cell Transplantation Therapy: A New Dawn With Pluripotent Stem Cell–Based Therapy

Nakanishi, E., Yamakado, H., Sawamoto, N., Takahashi, J., & Takahashi, R. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70500 · Cited by 1

Transplantation tolerance versus immune evasion: Mechanistic divergences and therapeutic frontiers for islet cell replacement

Deuse, T., & Schrepfer, S. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102888 · Cited by 1

Extending the residence period of allogeneic iPSC-derived invariant natural killer T cells in humanized mice by editing HLA class I expression

Chang, Y.-H., Aoki, T., Okoshi, M., Yamaguchi, M., Okura, H., Sasaki, S., Sasako, Y., Kira, S., Yakushiji-Kaminatsui, N., Matsuda, M., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1869698 · Cited by 1

Modeling myeloid cell development in health and disease using induced pluripotent stem cells

Tesakov, I., Nasri, M., Klimiankou, M., Fındık, B., Loskill, P., & Skokowa, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815809 · Cited by 1

Dissecting divergent outcomes in stem cell-derived dopamine cell therapy trials for Parkinson’s disease

Park, C. W., Park, S., Chung, S. J., Lee, P. H., & Kim, D. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.07.002 · Cited by 1

Hypoimmune platforms: from rejection to immune evasion and regulatory implications

Campo, F., Bellini, M. I., Scholz, H., Piemonti, L., & Citro, A. (2026) · Transplant International · doi:10.3389/ti.2026.16845 · Cited by 1

Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion

Kadyk, L. C., Okamura, R. M., & Talib, S. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0079 · Cited by 1

Tissue engineered heart repair

Jebran, A. F., Kutschka, I., & Zimmermann, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813706-2.00014-2 · Cited by 1

Xeno-free cultivation of human induced pluripotent stem cells for clinical applications

Saleh, F., Mondeh-Lowor, R., & de Peppo, G. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00001-2 · Cited by 1

Clinical Application of iPSC-Derived Cardiomyocytes in Patients with Advanced Heart Failure

Fujita, J., Tohyama, S., Kanazawa, H., Kishino, Y., Okada, M., Tanosaki, S., Someya, S., & Fukuda, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-86140-7_16 · Cited by 1

Current Status, Barriers, and Future Directions for Humanized Mouse Models to Evaluate Stem Cell–Based Islet Cell Transplant

Verhoeff, K. K., Marfil‐Garza, B. A., Cuesta‐Gomez, N., Jasra, I. T., Dadheech, N., & Shapiro, A. M. J. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_711 · Cited by 1

Off-the-Shelf Chimeric Antigen Receptor Immune Cells from Human Pluripotent Stem Cells

Cao, H., & Sugimura, R. (2022) · Cancer treatment and research · doi:10.1007/978-3-030-96376-7_9 · Cited by 1

A Review of Stem Cell Technology Targeting Hepatocyte Growth as an Alternative to Organ Transplantation

Goulart, E. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2716-7_9 · Cited by 1

iPS cell technologies toward overcoming neurological diseases

Kimura, T., & Muguruma, K. (2022) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22084 · Cited by 1

Ubiquitin–Proteasome System in the Induction and Maintenance of Cellular Pluripotency

Zubarev, I. V., Podenkova, U. I., Tomilin, A. N., & Цимоха, А. С. (2022) · Russian Journal of Developmental Biology · doi:10.1134/s1062360422060091 · Cited by 1

Hypoimmune cells resist rejection in monkeys

Borrego, A. B., & Gill, S. I. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-02013-1 · Cited by 1

Hiding from allogeneic NK cells and macrophages by a synthetic receptor.

Hotta, A., & Lee, J. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.10.005 · Cited by 2

Immune Evasive Stem Cell Islets

Cuozzo, F., Sordi, V., & Piemonti, L. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_14 · Cited by 1

Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives

Bogomiakova, M. E., Bogomazova, A. N., & Lagarkova, M. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050031 · Cited by 1

Scaling Stem Cells to Cure Millions of Patients with Diabetes: Approaches, Technology, and Future Directions

Verhoeff, K. K., & Shapiro, A. M. J. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_18 · Cited by 1

Gene editing enables non-invasive in vivo PET imaging of human induced pluripotent stem cell-derived liver bud organoids

Ashmore‐Harris, C., Ayabe, H., Yoshizawa, E., Arisawa, T., Takada, Y., Takebe, T., & Fruhwirth, G. O. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101406 · Cited by 1

Bioinspired Vascular Grafts

Miranda-Nieves, D., Ashour, A., & Chaikof, E. L. (2021) · Reference series in biomedical engineering · doi:10.1007/978-3-030-44211-8_15 · Cited by 1

Stem cell-derived pancreatic beta cells for the study and treatment of diabetes

Barra, J. M., & Russ, H. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001444 · Cited by 1

PECUU-ECM Patches

Ajaj, Y., Akingbesote, N. D., & Qyang, Y. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.03.003 · Cited by 1

Perfusability and immunogenicity of implantable pre-vascularized tissues recapitulating native capillary networkPreprint

Zhao, F., Sharma, D., Sharma, A., Hu, L., Chen, T.-A., Voon, S., Bayless, K. J., Goldman, J., & Walsh, A. J. (2022) · Research Square · doi:10.21203/rs.3.rs-2325499/v1 · Cited by 1

Whole Pancreas and Islet Cell Transplantation

Marfil‐Garza, B. A., Senior, P. A., & Shapiro, A. M. J. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch34 · Cited by 1

Hypoimmunogenic Genetically Modified Induced Pluripotent Stem Cells for Tissue Regeneration

Wright, S., & Issa, F. (2019) · Transplantation · doi:10.1097/tp.0000000000002754

Les cellules souches pluripotentes dans le traitement de l’insuffisance cardiaque

Desgres, M., & Menasché, P. (2019) · médecine/sciences · doi:10.1051/medsci/2019155 · Cited by 1

Bioinspired Vascular Grafts

Miranda-Nieves, D., Ashour, A., & Chaikof, E. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-18512-1_15-1

GM2-gangliosidosis, type I (Tay – Sachs disease) in the pediatrician practice

Zhurkova, N. V., Vashakmadze, N. D., Вахтанговна, С. Н., Gordeeva, O. B., Sergienko, N. S., & Zaharova, E. Y. (2021) · Педиатрическая фармакология · doi:10.15690/pf.v17i6.2199

Induced pluripotent stem cells in intestinal diseases

Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Okaruefe, C. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821269-1.00003-5

Development of a Gelfoam-based Three-dimensional Culture System to Promote Type II Alveolar Epithelial Cell Maturation for Future Delivery in Cell Therapy

Thanabalasingam, T. (2021) · TSpace (University of Toronto)

Advances in generating HLA-Universal platelets for transfusion medicine

Lau, W. W. Y., & Ghevaert, C. (2021) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2021.100053

Skeletal muscle engineering using human induced pluripotent stem cells for in vitro disease modeling

Tey, S.-R., Robertson, S., & Suzuki, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00006-2

Signaling pathways regulate cardiovascular lineage commitment of hPSCs

Han, P., & Cho, H. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00013-0

Engineered human brown adipocyte microtissues improved glucose and insulin homeostasis in high fat diet-induced obese and diabetic micePreprint

Wang, O., Han, L., Lin, H.-S., Tian, M., Zhang, S., Duan, B., Chung, S., Zhang, C., Lian, X., Wang, Y., et al. (2021) · bioRxiv · doi:10.1101/2021.10.11.463939

Medizintechnik, Chirurgie und Pandemiestrategien – an den Grenzen des Machbaren

Lange, A. (2021) · Springer eBooks · doi:10.1007/978-3-662-63055-6_5

Genom-Editierung – Therapieren von Erbkrankheiten und noch viel mehr

Lange, A. (2021) · Springer eBooks · doi:10.1007/978-3-662-63055-6_6

3D-Bioprinting in der regenerativen Therapie von Herz- und Gefäßerkrankungen

Berndt, R. (2021) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-021-00469-4

Allogeneic Immunity Following Transplantation of Pluripotent Stem Cell-Derived Cardiomyocytes

Shiba, Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-86140-7_5

The Guinea Pig Model in Cardiac Regeneration Research; Current Tissue Engineering Approaches and Future Directions

Stüdemann, T., & Weinberger, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-86140-7_7

A new generation of induced pluripotent stem cells for regenerative medicine

(2021) · Research outreach · doi:10.32907/ro-121-1132190580

3D-Bioprinting in der regenerativen Therapie von Herz- und Gefäßerkrankungen

Berndt, R. (2022) · Wiener klinisches Magazin · doi:10.1007/s00740-022-00443-2

Faculty Opinions recommendation of Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs.

Truskey, G. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737220683.793570184

Limiting Immunogenicity of Diabetic Retinopathy Patient-Derived Induced Pluripotent Stem Cells by Knocking out Human Leukocyte Antigen and Overexpressing Cluster of Differentiation 47

Khalid, M., Patel, H., Syed, S., & Lakhi, S. (2022) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.303

Stammzellforschung an und mit Affen: zwischen Grundlagen und Anwendung

Behr, R. (2022) · BIOspektrum · doi:10.1007/s12268-022-1824-4

Toward Improving Immunotolerance for Stem Cell-Derived IsletsPreprint

Zhou, Q., Li, H., Gerace, D., Nikolskly, I., Wang, X., Kenty-Ryu, J., Zhang, J.-P., Hinderhofer, M., Robinson, E., & Melton, D. (2022) · bioRxiv · doi:10.1101/2022.09.15.508091

Induced Pluripotent Stem Cells

Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_40

Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells

Murata, T., Otsuka, R., Sasaki, A., Kamatani, T., Wada, H., Yamakawa, H., Hasegawa, Y., & Seino, K.-I. (2023) · International Immunology · doi:10.1093/intimm/dxad008

Experimental Neurotransplantation for Cerebellar Ataxias

Cendelín, J., Buffo, A., Hirai, H., Magrassi, L., Manto, M. U., Mitoma, H., & Sherrard, R. M. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_18

De la biologie du développement à la thérapie cellulaire du diabète

Schreiber, V., & Gradwohl, G. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.05.009

Induced Pluripotent Stem Cells and Allogeneic Mesenchymal Stem Cell Therapy in Cardiovascular Diseases

Follin, B., Caluori, G., Dobrolińska, M. M., Stachura, J., Muzzamil, H., Wojakowski, W., Qayyum, A. A., & Jadczyk, T. (2023) · Springer eBooks · doi:10.1007/978-981-99-0722-9_3

Towards functional kidney organoids

Schumacher, A. (2023) · doi:10.26481/dis.20230926as

Scaling Stem Cells to Cure Millions of Patients with Diabetes: Approaches, Technology, and Future Directions

Verhoeff, K. K., & Shapiro, A. M. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_18-1

La rigenerazione del miocardio nello scompenso cardiaco: ieri, oggi e domani

(2024) · il Diabete · doi:10.30682/ildia2304f

Living donor organ transplantation—gene therapy

Crane, A., Müller, Y. D., Bromberg, J. S., & Meier, R. P. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23571-9.00048-7

Additional file 2 of Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells

Glaser, V., Flugel, C., Kath, J., Du, W., Drosdek, V., Franke, C., Stein, M., Prüß, A., Schmueck‐Henneresse, M., Volk, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22688654

Pluripotent Stem Cells in Myocardial Tissue Engineering and Heart Regeneration

Yusof, N. A. N. M., Esa, E., & Tan, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00084-6

Articular cartilage tissue engineering using genetically modified induced pluripotent stem cell lines

Gavrilov, N. S., Ignatyeva, N. V., Medvedeva, E. V., & Timashev, P. S. (2024) · Genes and Cells · doi:10.17816/gc633492

Dysregulation of immune tolerance to autologous iPSCs and their differentiated derivatives (review)

Bogomiakova, M. E., Bogomazova, A. N., & Lagarkova, M. A. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524050036

Considerations for nonclinical studies conducted to support the development of cellular therapies

Bolt, M. W., & Narayanan, P. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00011-0

Stem cell for PD: Technical considerations

Ibrahim, S. S., Elmligy, E., & Tharwat, E. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00008-6

Immune and Mutational Profile of Gene-Edited Low-Immunogenic Human Primary Cholangiocyte OrganoidsPreprint

Petrus-Reurer, S., Baez‐Ortega, A., Lei, W., Kumaran, G. K., Williamson, J. C., Jones, J. L., Trajkovski, D., Lawson, A. R. J., Mahbubani, K. T. A., Brodie, C. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.20.628680

Recent Advances and Future Challenges in the Immunology of Islet and Stem Cell-Derived Islet Transplantation

Teo, A. K. S., Tan, K. S. M., Koh, Y. X., Koh, A., & Teo, A. K. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00143-5

Recent Advances in Cutaneous Carcinoma Therapy Through Integrated Use of Immunotherapy and Nanotechnology

Dongsar, T. T., Bajaj, K., Dongsar, T. S., Ali, A., Hasan, N., & Ahmad, F. J. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096349248250113093025

Current Advancement in Stem Cell-Based Cardiac Regenerative Treatment in End-Stage Heart Failure

Poyraz, E. (2025) · Cardiology and cardiovascular medicine. · doi:10.5772/intechopen.1009805

Identification of HLA-A , HLA-B and HLA-C triple homozygous and double homozygous donors: a path towards synthetic superdonor Advanced Therapeutic Medicinal ProductsPreprint

Naumovas, D., Rojas-Araya, B., Polanco, C. M., Andrade, V., Čekauskienė, R., Valatkaitė-Rakštienė, B., Laurinaitytė, I., Jakubauskas, A., Stoškus, M., Griškevičius, L., et al. (2025) · medRxiv · doi:10.1101/2025.05.19.25327154

Stem Cell Therapy in Ischemic Heart Failure

Guo, Q., & Yang, H. (2025) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-025-00741-0

Stem cells could regenerate organs – but only if the body won’t reject them

Deuse, T. (2019) · doi:10.64628/aai.gt3hqup3m

Hypoimmunogenic human motor neurons induced from iPSCs in vivo substantially ameliorate ALS disease in large animal modelsPreprint

Zhang, N., Yang, Y., Chen, M.-Q., Zou, Q., Quan, L.-Q., Huang, J., Zhang, Q.-J., Zhao, Y., Ouyang, Z., Zhang, Z., et al. (2025) · bioRxiv · doi:10.1101/2025.09.03.673895

Identification of HLA-A, HLA-B, and HLA-C triple homozygous and double homozygous donors: a path toward synthetic superdonor advanced therapeutic medicinal products

Naumovas, D., Rojas-Araya, B., Polanco, C. M., Andrade, V., Čekauskienė, R., Valatkaite-Rakstiene, B., Laurinaitytė, I., Jakubauskas, A., Stoškus, M., Griškevičius, L., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1626787

REWRITE Enables Locus-Scale Engineering of Synthetic HLA Haplotypes in Human Pluripotent Stem CellsPreprint

Generoso, S., Levovitz, S., Jaramillo, S., Kim, M., Dara, S., Phen, S. F., Yi, B., Yanagi, T., DesMarais, T. L., Agmon, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676382 · Cited by 1

Application of Induced Pluripotent Stem Cells (iPSCs) in Hereditary and Viral Diseases of the Liver: Modeling and Treatment

Andriianov, V. S., Malyutina, A., Panferov, E., Karabelsky, A. V., Ivanov, R. A., Minskaia, E., & Reshetnikov, V. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199432

Genome Editing and Human-Induced Pluripotent Stem Cells Facilitate Parkinson’s Disease Modeling

Polanco, C. M., Inzunza, J., Nalvarte, I., & Arias, J. (2025) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-94101-6_3

Immunotherapy with Pro-regenerative Macrophages from Embryonic Stem Cells Ameliorate Osteoarthritis via TNFAIP3-Mediated ChondroprotectionPreprint

Zhuang, Z., Liu, Z., Su, H., Sun, W., Zhu, Q., Xu, J., Fang, J., Li, L., Shen, D., Zou, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.12.693855

Additional file 2 of Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey

Wang, X., Lu, M., Tian, X., Ren, Y., Li, Y., Xiang, M., & Chen, S. (2020) · Figshare · doi:10.6084/m9.figshare.12756787

Additional file 5 of Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey

Wang, X., Lu, M., Tian, X., Ren, Y., Li, Y., Xiang, M., & Chen, S. (2020) · Figshare · doi:10.6084/m9.figshare.12756796

Additional file 1 of Cell-based passive immunization for protection against SARS-CoV-2 infection

Sawula, E., Miersch, S., Jong, E. D., Li, C., Chou, F.-Y., Tang, J. K., Saberianfar, R., Harding, J., Sidhu, S. S., & Nagy, A. (2024) · Figshare · doi:10.6084/m9.figshare.26636607

Additional file 3 of Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey

Wang, X., Lu, M., Tian, X., Ren, Y., Li, Y., Xiang, M., & Chen, S. (2020) · Figshare · doi:10.6084/m9.figshare.12756790

Additional file 1 of Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity

Tsuneyoshi, N., Hosoya, T., Takeno, Y., Saitoh, K., Murai, H., Amimoto, N., Tatsumi, R., Watanabe, S., Hasegawa, Y., Kikkawa, E. F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741663

Additional file 1 of iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors

Bogomiakova, M. E., Sekretova, E. K., Anufrieva, K. S., Khabarova, P. O., Kazakova, A. N., Bobrovsky, P. A., Grigoryeva, T. V., Eremeev, A., Lebedeva, O. S., Bogomazova, A. N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624430

Additional file 4 of Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey

Wang, X., Lu, M., Tian, X., Ren, Y., Li, Y., Xiang, M., & Chen, S. (2020) · Figshare · doi:10.6084/m9.figshare.12756793

Additional file 1 of Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey

Wang, X., Lu, M., Tian, X., Ren, Y., Li, Y., Xiang, M., & Chen, S. (2020) · Figshare · doi:10.6084/m9.figshare.12756784

Additional file 1 of Improving cell survival and engraftment in vivo via layer-by-layer nanocoating of hESC-derived RPE cells

Ru, L., Wu, N., Wei, K., Zeng, Y., Li, Q., Weng, C., Ren, C., Ren, B., Huo, D., Li, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13290500

Additional file 1 of Enhanced survival of hypoimmunogenic otic progenitors following intracochlear xenotransplantation: repercussions for stem cell therapy in hearing loss models

Andrade da Silva, L. H., Heuer, R. A., Roque, C. B., McGuire, T. L., Hosoya, T., Kimura, H., Tamura, K., & Matsuoka, A. J. (2023) · Figshare · doi:10.6084/m9.figshare.22623832

Additional file 1 of Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity

Chen, Y., Zhou, Y., Zhou, Z., Fang, Y., Ma, L., Zhang, X., Xiong, J., & Liu, L. (2023) · Figshare · doi:10.6084/m9.figshare.22609745

Additional file 2 of iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors

Bogomiakova, M. E., Sekretova, E. K., Anufrieva, K. S., Khabarova, P. O., Kazakova, A. N., Bobrovsky, P. A., Grigoryeva, T. V., Eremeev, A., Lebedeva, O. S., Bogomazova, A. N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624433

Site-specific integration of transposon via engineered piggyBac transposasePreprint

Xu, N., Han, L., Hu, X., Fang, Y., Wu, L., Wang, X., Tu, H., Deng, X., Cong, W., Sun, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700476

The Role of Stem Cell Therapy in Treating Type 1 Diabetes and Scientific Advances in Evading an Immune Response

Maloney, K., Azar, W. S., McKenney, J., Upasani, P., & Gallicano, I. (2025) · Harvard Medical Student Review · doi:10.65539/xdtar040

Towards safer iPSC-CM transplantation: steroid-sparing immunosuppression and arrhythmia prevention

Wexler, Y., & Gepstein, L. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag021

Vision Restoration in Degenerative Retinal Diseases Using Stem Cells

Viswanathan, H., Goyal, I., Rana, S., Singh, S., Singh, R., & Senjam, S. S. (2025) · Journal of the Epidemiology Foundation of India · doi:10.56450//jefi.2025.v3i1suppl.005

Generation of Functional β Cells from Pluripotent Stem Cells: Advances and Applications

Khashim, Z., & Peterson, Q. P. (2025) · Biochemistry · doi:10.5772/intechopen.1011979

Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity

Tsuneyoshi, N., Hosoya, T., Takeno, Y., Saitoh, K., Murai, H., Amimoto, N., Tatsumi, R., Watanabe, S., Hasegawa, Y., Kikkawa, E. F., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03810-4 · Cited by 42

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells

Wang, B., Iriguchi, S., Waseda, M., Ueda, N., Ueda, T., Xu, H., Minagawa, A., Ishikawa, A., Yano, H., Ishi, T., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00730-z · Cited by 189

Hypoimmunogenic Genetically Modified Induced Pluripotent Stem Cells for Tissue Regeneration

Wright, S., & Issa, F. (2019) · Transplantation · doi:10.1097/tp.0000000000002754

At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines?

Bogomiakova, M. E., Валерьевич, Е. А., & Lagarkova, M. A. (2019) · Molecular Biology · doi:10.1134/s0026893319050042 · Cited by 7

183-OR: Overcoming Immunological Barriers for “Off-the-Shelf” iPSC-Derived Islets

HU, X., White, K. A., Olroyd, A. G., DeJesus, R., Dominguez, A. A., Dowdle, W. E., CHU, E. Y. L., Friera, A. M., Young, C., Wells, F., et al. (2022) · Diabetes · doi:10.2337/db22-183-or